Original article
Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals
Evolución de la porfiria cutánea tarda asociada al VHC tras obtenerse respuesta virológica sostenida del VHC mediante el uso de antivirales de acción directa
Lucio J. García-Frailea,
, Luisa García-Bueyb, Concepción Alonso Cerezoc, Jesús Sanz Sanza, Ignacio de los Santos Gila
Corresponding author
a Service of Infectious Diseases and Internal Medicine, Hospital Universitario de la Princesa, IIP, Universidad Autónoma de Madrid, Madrid, Spain
b Gastroenterology and Hepatology Service, Hospital Universitario de la Princesa, IIP, Universidad Autónoma de Madrid, Spain
c Genetic Unit, Hospital Universitario de la Princesa, IIP, Spain
Read
683
Timeswas read the article
178
Total PDF
505
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 30 | 5 | 35 |
| 2024 October | 23 | 10 | 33 |
| 2024 September | 45 | 10 | 55 |
| 2024 August | 43 | 11 | 54 |
| 2024 July | 35 | 16 | 51 |
| 2024 June | 31 | 10 | 41 |
| 2024 May | 32 | 15 | 47 |
| 2024 April | 35 | 18 | 53 |
| 2024 March | 10 | 12 | 22 |
| 2024 February | 10 | 3 | 13 |
| 2024 January | 7 | 0 | 7 |
| 2023 December | 12 | 0 | 12 |
| 2023 November | 30 | 0 | 30 |
| 2023 October | 19 | 0 | 19 |
| 2023 September | 10 | 0 | 10 |
| 2023 August | 12 | 0 | 12 |
| 2023 July | 13 | 0 | 13 |
| 2023 June | 13 | 3 | 16 |
| 2023 May | 2 | 0 | 2 |
| 2023 April | 5 | 1 | 6 |
| 2023 March | 6 | 5 | 11 |
| 2023 February | 4 | 4 | 8 |
| 2023 January | 9 | 7 | 16 |
| 2022 December | 6 | 8 | 14 |
| 2022 November | 5 | 5 | 10 |
| 2022 October | 5 | 5 | 10 |
| 2022 September | 5 | 4 | 9 |
| 2022 August | 5 | 5 | 10 |
| 2022 July | 1 | 1 | 2 |
| 2022 June | 4 | 4 | 8 |
| 2022 May | 3 | 2 | 5 |
| 2022 April | 14 | 2 | 16 |
| 2022 March | 21 | 6 | 27 |
| 2021 October | 0 | 4 | 4 |
| 2021 September | 0 | 2 | 2 |
Show all
